Incretin-based weight loss drugs may also trim lean mass, meta-analysis finds
A meta-analysis of five phase 3 trials found that incretin-based therapies lowered DXA-measured lean body mass versus comparators, though certainty ...
A meta-analysis of five phase 3 trials found that incretin-based therapies lowered DXA-measured lean body mass versus comparators, though certainty ...
A new perspective in Advances in Therapy argues that lean mass loss during incretin therapy reflects physiological body composition remodeling ...
A new review proposes a hierarchical nutritional framework inspired by the traditional Chinese medicine concept of Jun-Chen-Zuo-Shi to individualize the ...
A new review finds that muscle mass, fat distribution, and sarcopenic obesity strongly influence chemotherapy toxicity in early-stage breast cancer, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine